March 24, 2026
1 min read

UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta

UCB will build a new manufacturing facility near its U.S. headquarters in Atlanta, Georgia. It will become the first major manufacturing facility in the U.S. for the rapidly growing Belgium-based company and will produce biologics. The company did not reveal how much it plans to spend to build the plant.

Leave a Reply

Your email address will not be published.

Previous Story

New Lyme Disease Vaccine Shows Strong Results in Trial MedNews

Next Story

STAT+: How will Trump handle the CDC and ACIP?

Previous Story

New Lyme Disease Vaccine Shows Strong Results in Trial MedNews

Next Story

STAT+: How will Trump handle the CDC and ACIP?

Latest from Blog

Go toTop